Across North America, the acquired cystic kidney disease treatment landscape is benefiting from well-established healthcare infrastructure, growing investment in renal care, and continued pharmaceutical innovation. The region's strong presence of leading drug manufacturers, research institutions, and healthcare providers supports the development and adoption of advanced therapeutic approaches....